Kura Oncology appoints Michael Vasconcelles, M.D. to board and compensation committee

Kura Oncology, Inc.

Appointed as Class III director with term expiring at 2026 annual meeting.
Annual cash retainer $40,000 for board service plus $7,500 for Compensation Committee.
Granted option to purchase 52,000 shares (3-year vest) and 17,333 shares (1-year cliff).
Eligible for future automatic annual option grants of 26,000 shares.
Standard indemnification agreement; no reportable transactions under Item 404.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael J. Vasconcelles, M.D.

Class III Director

KURA · Kura Oncology, Inc.

Effective: 2024-09-13
Filed: September 17, 2024, 7:59 PM ET

On September 13, 2024, the Board of Directors (the “Board”) of Kura Oncology, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Michael J. Vasconcelles, M.D. as (i) a Class III director of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael J. Vasconcelles, M.D. was appointed as Class III Director at Kura Oncology, Inc..

Action: appointed
Role: Class III Director

Exact text from the filing

On September 13, 2024, the Board of Directors (the “Board”) of Kura Oncology, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Michael J. Vasconcelles, M.D. as (i) a Class III director of the Company

View on SEC.gov

Kura Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-220529

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.